Forbes March 26, 2024
Topline
Supreme Court justices suggested Tuesday they’re unlikely to roll back federal approvals of abortion drug mifepristone, with even conservative justices expressing skepticism that the anti-abortion rights advocates who brought a case challenging the drug’s legality have standing to sue as the court heard its most consequential abortion case since it overturned Roe v. Wade in 2022.
Key Facts
What To Watch For
Justices will rule in the case within the next several months, sometime before the court’s term wraps up in late June. Mifepristone remains broadly available—with the 2016 and 2021 approvals in place—while the court deliberates on the case, as justices paused the appeals court ruling that restricted the drug in April 2023.
What We Don’t Know
What...
Today's Sponsors
Today's Sponsor